These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2855572)

  • 21. Enteric-coated solid dosage forms containing sodium bicarbonate as a drug substance: an exception from the rule?
    Breitkreutz J; Gan TG; Schneider B; Kalisch P
    J Pharm Pharmacol; 2007 Jan; 59(1):59-65. PubMed ID: 17227621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation of rotundine-chitosan gelled granules and their drug-release tests].
    Liu XJ; Xie SS; Zhang YX; Zhang JL; Zhang D; Wang YL; Ni D; Li D; Lu M; Ye QT
    Yao Xue Xue Bao; 1991; 26(10):782-7. PubMed ID: 1688072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan salts as nasal sustained delivery systems for peptidic drugs.
    Cerchiara T; Luppi B; Bigucci F; Zecchi V
    J Pharm Pharmacol; 2003 Dec; 55(12):1623-7. PubMed ID: 14738587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colon-specific delivery tablets of sodium 4-aminosalicylic acid.
    Li Y; Li HJ; Yang GR; Gu WP; Ma YK; Zhang MH; Sun J; Sun SJ
    Yao Xue Xue Bao; 2006 Oct; 41(10):927-32. PubMed ID: 17184108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.
    Corti G; Cirri M; Maestrelli F; Mennini N; Mura P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):303-9. PubMed ID: 17616379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained delivery of captopril from floating matrix tablets.
    Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
    Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and evaluation of intragastric buoyant preparations.
    Machida Y; Inouye K; Tokumura T; Iwata M; Nagai T
    Drug Des Deliv; 1989 Mar; 4(2):155-61. PubMed ID: 2765108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buoyant sustained release granules based on chitosan: comments on the article by Inouye et al.
    Touitou E
    Drug Des Deliv; 1989 Dec; 5(2):167. PubMed ID: 2577987
    [No Abstract]   [Full Text] [Related]  

  • 33. Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs.
    Rouge N; Cole ET; Doelker E; Buri P
    Pharm Dev Technol; 1998 Feb; 3(1):73-84. PubMed ID: 9532602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate].
    Miyazaki T; Komuro T; Yomota C; Okada S
    Eisei Shikenjo Hokoku; 1990; (108):95-7. PubMed ID: 1364368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparticulate chitosan-dispersed system for drug delivery.
    Shimono N; Takatori T; Ueda M; Mori M; Nakamura Y
    Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):620-4. PubMed ID: 12808235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force.
    Yao T; Yamada M; Yamahara H; Yoshida M
    Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1510-4. PubMed ID: 9332004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of heat on characteristics of chitosan film coated on theophylline tablets.
    Nunthanid J; Wanchana S; Sriamornsak P; Limmatavapirat S; Luangtana-anan M; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2002 Sep; 28(8):919-30. PubMed ID: 12378961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies of oral "quick-release" and "slowrelease" iron preparations in the postabsorption serum iron concentration test].
    Kilchling H
    Arzneimittelforschung; 1975 Jan; 25(1):105-10. PubMed ID: 1173763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained release of indomethacin from chitosan granules in beagle dogs.
    Miyazaki S; Yamaguchi H; Yokouchi C; Takada M; Hou WM
    J Pharm Pharmacol; 1988 Sep; 40(9):642-3. PubMed ID: 2907032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colon delivery of prednisolone based on chitosan coated polysaccharide tablets.
    Park HS; Lee JY; Cho SH; Baek HJ; Lee SJ
    Arch Pharm Res; 2002 Dec; 25(6):964-8. PubMed ID: 12510854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.